Pakkumised

Rohkem pakkumisi, leht 41943

Iga allpool olev pakkumine on 13–97% soodsam. Hinnad sünkroonitakse reaalajas kontrollitud poodidest.

Guangzhou Risong Intelligent Technology Holding Co., Ltd. (688090.SS) DCF Valuation
-40%

Guangzhou Risong Intelligent Technology Holding Co., Ltd. (688090.SS) DCF Valuation

dcfmodeling.comPLPL
15,00 PLN25,00 PLN
Guangzhou Risong Intelligent Technology Holding Co., Ltd. (688090.SS): PESTLE Analysis [Dec-2025 Updated]
-22%

Guangzhou Risong Intelligent Technology Holding Co., Ltd. (688090.SS): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Guangzhou Risong Intelligent Technology Holding Co., Ltd. (688090.SS): Marketing Mix Analysis
-22%

Guangzhou Risong Intelligent Technology Holding Co., Ltd. (688090.SS): Marketing Mix Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Guangzhou Risong Intelligent Technology Holding Co., Ltd. (688090.SS): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Guangzhou Risong Intelligent Technology Holding Co., Ltd. (688090.SS): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): Ansoff Matrix
-22%

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): Ansoff Matrix

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Guangzhou Risong Intelligent Technology Holding Co., Ltd. (688090.SS): VRIO Analysis
-22%

Guangzhou Risong Intelligent Technology Holding Co., Ltd. (688090.SS): VRIO Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Guangzhou Risong Intelligent Technology Holding Co., Ltd. (688090.SS): SWOT Analysis [Dec-2025 Updated]
-22%

Guangzhou Risong Intelligent Technology Holding Co., Ltd. (688090.SS): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): Canvas Business Model
-22%

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): Canvas Business Model

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): BCG Matrix [Dec-2025 Updated]
-22%

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): Marketing Mix Analysis
-22%

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): Marketing Mix Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) DCF Valuation
-40%

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) DCF Valuation

dcfmodeling.comPLPL
15,00 PLN25,00 PLN
Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): PESTLE Analysis [Dec-2025 Updated]
-22%

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): VRIO Analysis
-22%

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): VRIO Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): SWOT Analysis [Dec-2025 Updated]
-22%

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): BCG Matrix [Dec-2025 Updated]
-22%

Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): Ansoff Matrix
-22%

Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): Ansoff Matrix

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): Canvas Business Model
-22%

Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): Canvas Business Model

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS) DCF Valuation
-40%

Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS) DCF Valuation

dcfmodeling.comPLPL
15,00 PLN25,00 PLN
Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): SWOT Analysis [Dec-2025 Updated]
-22%

Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): PESTLE Analysis [Dec-2025 Updated]
-22%

Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): Marketing Mix Analysis
-22%

Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): Marketing Mix Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): VRIO Analysis
-22%

Fujian Foxit Software Development Joint Stock Co.,Ltd (688095.SS): VRIO Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN